Early detection of chemotherapy-related cardiotoxicity [ 2013 - 2016 ]

Research Grant

Researchers: Prof Liza Thomas (Principal investigator) ,  A/Pr David Richards ,  Prof Paul Harnett

Brief description This project examines myocardial dysfunction in breast cancer patients treated with anthracycline chemotherapy. Chemotherapy related cardiotoxicity is often asymptomatic until significant cardiac dysfunction occurs. Cardiac function is evaluated by LV ejection fraction (LVEF), which is a coarse measure of cardiac function. Strain analysis measure myocardial deformation and is more sensitive to subclinical cardiac dysfunction, and demonstrates alterations prior to the development of reduced LVEF.

Funding Amount $AUD 269,401.45

Funding Scheme Project Grants

Notes Standard Project Grant